• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文OA文献 >Clinical Validation of a New Triplex Real-Time Polymerase Chain Reaction Assay for the Detection and Discrimination of Herpes simplex Virus Types 1 and 2
【2h】

Clinical Validation of a New Triplex Real-Time Polymerase Chain Reaction Assay for the Detection and Discrimination of Herpes simplex Virus Types 1 and 2

机译：一种新的三重实时聚合酶链反应检测和鉴别1型和2型单纯疱疹病毒的临床验证

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

A new triplex real-time polymerase chain reaction (PCR) assay for Herpes simplex virus (HSV) (artus HSV-1/2 TM PCR kit, QIAGEN) was evaluated. This assay simultaneously uses three differently labeled probes targeted to HSV-1 (FAM), HSV-2 (NED), and to the manufacturer's Internal Control (VIC). HSV-1/2 typing capability and quantitation accuracy were determined using HSV stocks and quality control panels. Performance in routine clinical testing was compared with a nested HSV-1/2 PCR assay. Dilution series and quality control panel testing revealed an approximately 10-fold higher HSV-2 sensitivity in real-time PCR compared with an in-house nested PCR assay. The sensitivity for HSV-1 was comparable in both assays. All HSV-positive proficiency panel samples (n = 21) and virus stocks were typed correctly as HSV-1 or HSV-2 using real-time PCR. Quantitation correlated well with reference values (HSV-1, r = 0.98; HSV-2, r = 0.88), and 95% detection limits were determined as 9.4 HSV-2 copies/reaction and 18 HSV-1 copies/reaction. Based on Ct values, the mean intra-assay coefficient of variation was 1%, whereas the interassay coefficient of variations were 2.7% and 2.5% for HSV-1 and -2, respectively. Testing of 309 clinical samples resulted in 100% specificity and 97% sensitivity. In conclusion, the artus HSV-1/2 TM PCR kit represents an excellent tool for the detection and differentiation of HSV-1 and -2 in clinical samples.
机译：评估了单纯疱疹病毒（HSV）的新的三重实时聚合酶链反应（PCR）测定法（Artus HSV-1 / 2 TM PCR kit，QIAGEN）。此测定法同时使用针对HSV-1（FAM），HSV-2（NED）和制造商内部控制（VIC）的三种不同标记的探针。 HSV-1 / 2分型能力和定量准确性使用HSV库存和质量控制面板确定。将常规临床测试中的性能与巢式HSV-1 / 2 PCR分析进行了比较。稀释系列和质量控制小组测试显示，与内部嵌套式PCR测定法相比，实时PCR的HSV-2敏感性高约10倍。在两种测定中，HSV-1的敏感性均相当。使用实时PCR将所有HSV阳性熟练度样本样本（n = 21）和病毒库正确键入为HSV-1或HSV-2。定量与参考值（HSV-1，r = 0.98； HSV-2，r = 0.88）很好地相关，测定95％的检出限为9.4 HSV-2拷贝/反应和18 HSV-1拷贝/反应。基于Ct值，平均批内变异系数为1％，而HSV-1和-2批间变异系数分别为2.7％和2.5％。对309个临床样品的测试得出100％的特异性和97％的灵敏度。总之，Artus HSV-1 / 2 TM PCR试剂盒是检测和区分临床样品中HSV-1和-2的极佳工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号